RE
Revelation Biosciences, Inc.
REVB · NASDAQ
$0.93 -4.90% (-$0.05)
1M -15.42%
Market Cap $3.64M
P/E Ratio -
Div. Yield -
ROE 100.20%
Bulios Fair Price
$0.86
7.6% downside
Trenutna cena
$0.93
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica REVB trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/B 0.36x
EV/EBITDA N/A
P/S N/A
Growth
100 /100
Growing Book val. growth 103.44%
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
0 /100
Poor ROE 100.20%
ROA 86.02%
Asset turnover 0.00x
Debt
100 /100
Low Current ratio 6.21x
Debt/Equity 0.07x
Net debt/EBITDA N/A
Stability
19 /100
Unstable EPS volatility 594.17%
Profitable years 0
Beta -0.17x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o REVB
Online
Sector
Healthcare
Industry
Biotechnology
CEO
James Rolke
Employees
8
Headquarters
San Diego
Prihajajoči dogodki
05 NOV.
Earnings
Upcoming earnings report